Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia 8Lymphoma 7Breast Neoplasms 6Lymphoma, Follicular 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Kidney Neoplasms 3Wilms Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Leukemia, Megakaryoblastic, Acute 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Testicular Neoplasms 1Testicular Germ Cell Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Pleuropulmonary blastoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cisplatin 4Paclitaxel 3Docetaxel 3Taxes 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Immunohistochemistry 2Gene Expression Profiling 2Gemcitabine 2Carboplatin 2vandetanib 1tumor necrosis factor-alpha, CNGRC fusion protein, human 1mercaptoundecahydrododecaborate 1bicalutamide 1Vorinostat 1Triptorelin Pamoate 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Pilocarpine 1Methotrexate 1Irinotecan 1In Situ Hybridization 1Erlotinib Hydrochloride 1Doxorubicin 1Chemotherapy, Adjuvant 1CP protocol 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 14-boronophenylalanine-fructose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Salivary Gland Neoplasms × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01619618 2017-05-17

Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial

Eastern Cooperative Oncology Group

Completed
183 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡